1. CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: Effectiveness and safety in 16 patients 
Fei Gao, Chuanxing Li, Yangkui Gu, Jinhua Huang, Peihong Wu 
European Journal of Radiology 
Volume 82, Issue 2, Pages e70-e75 (February 2013)
DOI: /j.ejrad
Copyright © Terms and Conditions

2. Fig. 1
Pre-planning of 125I brachytherapy. (A) Three-dimensional image of tumor on computerized radioactive treatment planning system (TPS). (B) Two-dimensional graph of planar implantation and dose distribution on TPS. (C) A dose–volume histogram (DVH) of tumor and surrounding organs on TPS.
European Journal of Radiology  , e70-e75DOI: ( /j.ejrad )
Copyright © Terms and Conditions

3. Fig. 2
Case 1. (A) Mediastinal metastatic lymph nodes recurrence from esophageal cancer after surgery. (B) During brachytherapy, an applicator accurately inserted into the tumor to implant 125I seeds. (C) Four months after brachytherapy, tumor disappeared, with well distributed radioactive seeds remaining only.
European Journal of Radiology  , e70-e75DOI: ( /j.ejrad )
Copyright © Terms and Conditions

4. Fig. 3
Case 2. (A) Mediastinal metastatic lymph nodes recurrence from esophageal cancer after radiotherapy and chemotherapy. (B) During brachytherapy, an applicator accurately inserted into the tumor to implant 125I seeds. (C) Six months after brachytherapy, tumor disappeared, with well distributed radioactive seeds remaining only.
European Journal of Radiology  , e70-e75DOI: ( /j.ejrad )
Copyright © Terms and Conditions